Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed London Stock Exchange - 04/17 11:15:38 am
1556.5 GBp   -0.45%
4h ago GSK, facing bribery claims, battles to build new sales model
5h ago GLAXOSMITHKLINE : Glaxo Confirms Investigations In Jordan, Lebanon Operatio..
9h ago GLAXOSMITHKLINE : Fresh bribery claims hit Glaxo
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline plc : Director/PDMR Shareholding

05/03/2012 | 02:11pm US/Eastern
Recommend:
0

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
4h ago GSK, facing bribery claims, battles to build new sales model
5h ago GLAXOSMITHKLINE : Glaxo Confirms Investigations In Jordan, Lebanon Operations
9h ago GLAXOSMITHKLINE : Fresh bribery claims hit Glaxo
1d agoDJADR Shares End Higher; Credit Suisse, ASML Shares Active
1d ago GLAXOSMITHKLINE : GSK statement on media reports
1d agoDJGLAXOSMITHKLINE : Glaxo Investigating Bribery Claims in Jordan and Lebanon
1d agoDJGLAXOSMITHKLINE : Glaxo Investigating Bribery Claims in Jordan and Lebanon
1d ago GLAXOSMITHKLINE : GSK says investigating claims of bribery in Jordan, Lebanon
1d ago GLAXOSMITHKLINE : discloses new bribery inquiries
1d ago GLAXOSMITHKLINE : GSK receives US approval for once-weekly type 2 diabetes treat..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF